
Ácidos Graxos e Derivados Lipídicos
Os ácidos graxos são moléculas formadas por uma longa cadeia de hidrocarbonetos com um grupo carboxila (-COOH) em uma extremidade. Essas estruturas conferem-lhes uma grande capacidade de interagir com as membranas celulares e desempenham papéis fundamentais no metabolismo energético, no armazenamento de gorduras e na regulação hormonal. Os derivados dos ácidos graxos são utilizados em cosméticos, produtos farmacêuticos e como componentes na produção de biocombustíveis.
Na CymitQuimica, oferecemos ácidos graxos e seus derivados para aplicações em química orgânica, bioquímica e desenvolvimento farmacêutico.
Foram encontrados 32246 produtos de "Ácidos Graxos e Derivados Lipídicos"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
8-ethyl-4-(4-methyl-3-nitrobenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid
CAS:Pureza:95.0%Peso molecular:377.39700317382814-(3,5-dichlorobenzoyl)-8-ethyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid
CAS:Pureza:95.0%Peso molecular:387.2600097656252-Hydroxy-6-methylpyridine-3,4-dicarboxylic acid
CAS:Pureza:95.0%Cor e Forma:SolidPeso molecular:197.145996093752-[4-(3-Chlorophenyl)piperazin-1-yl]-2-(4-fluorophenyl)acetic acid
CAS:Peso molecular:348.79998779296875N-Des(4-Fluorophenyl)-N-(3-fluorophenyl) Ezetimibe
CAS:Fórmula:C24H21F2NO3Cor e Forma:Off White SolidPeso molecular:409.43Glutaric Acid
CAS:<p>Applications Glutaric Acid is an organic acid found in human urine which may be used for the detection of metabolic or other health disorders.<br>References Christou, C., et. al.: J. Chromatogr. B. Anal. Tech. Biomed. Life Sci., 964, 195 (2014)<br></p>Fórmula:C5H8O4Cor e Forma:White PowderPeso molecular:132.111-(4-fluorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid
CAS:Pureza:95.0%Peso molecular:284.29000854492198-methyl-4-(2-phenylacetyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid
CAS:Pureza:95.0%Peso molecular:317.385009765625(3S,4S)-3-Hexyl-4-[(2R)-2-hydroxytridecyl]-2-oxetanone
CAS:Produto Controlado<p>Impurity Orlistat USP Related Compound A<br>Applications (3S,4S)-3-Hexyl-4-[(2R)-2-hydroxytridecyl]-2-oxetanone (Orlistat USP Related Compound A) is an analog of Tetrahydrolipstatin, an inhibitor of the hydrolysis of endocannabinoid 2-arachidonoylglycerol (2-AG), also an intermediate in the preparation of Orlistat (O686500).<br>References Mechoulam, R., et al.: Biochem. Pharmacol., 50, 83 (1995), Bisogno, T., et al.: J. Cell Biol., 163, 463 (2003), Di Marzo, V., et al.: Nat. Rev. Drug Discovery, 7, 438 (2008), Ortar, G., et al.: J. Med. Chem., 51, 6970 (2008),<br></p>Fórmula:C22H42O3Cor e Forma:NeatPeso molecular:354.57(R)-4-(BOC-AMINO)-3-HYDROXYBUTANOIC ACID
CAS:Pureza:97.0%Cor e Forma:SolidPeso molecular:219.23699951171875Methyl 3-(5-(2-ethoxy-2-oxoethyl)-2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl)propanoate
CAS:Pureza:98%Peso molecular:316.30599975585944-Hydroxy Atorvastatin Disodium Salt
CAS:<p>Applications A metabolite of Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastatin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.<br>References Smith, S., et al.: Am. J. Cardiol., 80, 10H (1997), Jacobsen, W., et al.: Drug Metab. Dispos., 28, 1369 (2000), Istvan, E., et al.: Science, 292, 1160 (2001), Tabernero, L., et al.: J. Biol. Chem., 278, 19933 (2003), Bratton, L., et al.: Bioorg. Med. Chem., 15, 5576 (2007),<br></p>Fórmula:C33H33FN2Na2O6Cor e Forma:White To BrownPeso molecular:618.60(4-Bromo-5-cyclopropyl-3-trifluoromethyl-pyrazol-1-yl)-acetic acid
CAS:Fórmula:C9H8BrF3N2O2Pureza:95.0%Cor e Forma:SolidPeso molecular:313.0746-cyclopropyl-1-(4-fluorophenyl)-3-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid
CAS:Pureza:95.0%Peso molecular:339.3699951171875Niflumic Acid
CAS:Produto Controlado<p>Applications Anti-inflammatory. Selective cyclooxygenase-2 (COX-2) inhibitor.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Glasson, et al.: Biochem, Pharmacol., 18, 633 (1969), Boissier, et al.: Therapie, 26, 211 (1971), Sorenson, J.R.J., et al.: J. Med. Chem., 19, 135 (1976), Barnett, J., et al.: Biochim. Biophys. Acta, 1209, 130 (1994), Johnson, J.L., et al.: Arch. Biochem. Biophys., 324, 26 (1995),<br></p>Fórmula:C13H9F3N2O2Cor e Forma:Light YellowPeso molecular:282.22(3’S,3R,4S)-Desfluoro Ezetimibe
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications (3’S,3R,4S)-Desfluoro Ezetimibe is an impurity of the cholesterol absorption inhibitor Ezetimibe (E975000).<br>References Gajjar, A.K., Open. Con. Proceed. J., 2, 108 (2011);<br></p>Fórmula:C24H22FNO3Cor e Forma:NeatPeso molecular:391.43Ezetimibe Phenoxy β-D-Glucuronide
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications Phase-II metabolite of Ezetimibe, an antihyperlipoproteinemic. A Cholesterol absorption inhibitor.This compound is very hygroscopic. Handle with care.<br>References van Heek, M., at al.: J. Pharmacol. Exp. Ther., 283, 157 (1997), van Heek, M., at al.: Brit. J. Pharmacol., 129, 1748 (2000)<br></p>Fórmula:C30H29F2NO9Cor e Forma:White To Light BrownPeso molecular:585.55(8-Benzyl-2,4-dioxo-1,3,8-triaza-spiro[4.5]dec-3-yl)-acetic acid
CAS:Pureza:95.0%Peso molecular:317.34500122070312-(4-Chlorophenyl)-2,3-dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid
CAS:Pureza:95%Peso molecular:301.679992675781253,5-Bis(methylsulfonyl)benzoic acid
CAS:Fórmula:C9H10O6S2Pureza:95.0%Cor e Forma:SolidPeso molecular:278.295,7-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylic acid
CAS:Fórmula:C8H8N4O2Pureza:95%Cor e Forma:SolidPeso molecular:192.178(S)-3-Methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanoic acid
CAS:Pureza:97%Peso molecular:200.23800659179688(6H-Dibenz[c,e][1,2]oxaphosphorin-6-ylmethyl)-p-oxide-butanedioic acid
CAS:Pureza:95.0%Peso molecular:346.2749938964844Ref: 10-F979169
5mgA consultar10mgA consultar25mgA consultar50mgA consultar100mgA consultar250mgA consultar2-(1,3-Dimethyl-1 H -pyrazol-4-yl)-quinoline-4-carboxylic acid
CAS:Cor e Forma:SolidPeso molecular:267.28799438476568-ethyl-4-(4-nitrobenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid
CAS:Pureza:95.0%Peso molecular:363.36999511718753-(1-METHYL-1H-PYRAZOL-4-YL)QUINOLINE-6-CARBOXYLIC ACID
CAS:Pureza:95.0%Peso molecular:253.261001586914068-methyl-4-(3-nitrobenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid
CAS:Pureza:95.0%Peso molecular:349.34298706054693-([(TERT-BUTOXY)CARBONYL](METHYL)AMINO)CYCLOBUTANE-1-CARBOXYLIC ACID
CAS:Pureza:95.0%Peso molecular:229.27600097656252,3-Pyridinedicarboxylic Acid
CAS:Produto Controlado<p>Applications An inhibitor of glucose synthesis.<br>References Martirosyan, A., et al.: Biochem. Pharmacol., 68, 1729 (2004),<br></p>Fórmula:C7H5NO4Cor e Forma:Off White SolidPeso molecular:167.121-Piperidin-1-yl-cyclohexanecarboxylic acid
CAS:Fórmula:C12H21NO2Cor e Forma:SolidPeso molecular:211.305(S)-2-Bromo-3-methylbutyric acid
CAS:Pureza:95.0%Cor e Forma:Solid, No data available.Peso molecular:181.02900695800784-(2-methoxyphenyl)-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-6-carboxylic acid
CAS:Pureza:95.0%Peso molecular:273.29199218752,3-Di-furan-2-yl-quinoxaline-6-carboxylic acid
CAS:Cor e Forma:SolidPeso molecular:306.27700805664064-(3-methoxybenzoyl)-8-methyl-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid
CAS:Pureza:95.0%Peso molecular:333.38400268554691-(pyridin-3-ylmethyl)-1H-benzimidazole-5-carboxylic acid
CAS:Pureza:95.0%Peso molecular:253.261001586914063-{[1,1'-biphenyl]-4-yl}-5-methyl-4,5-dihydro-1,2-oxazole-5-carboxylic acid
CAS:Pureza:95.0%Peso molecular:281.3110046386719[2-oxo-5-(trifluoromethyl)-1(2H)-pyridinyl]acetic acid
CAS:Pureza:95.0%Cor e Forma:SolidPeso molecular:221.13499450683594Ref: 10-F314892
1gA consultar5gA consultar2.5gA consultar50mgA consultar100mgA consultar500mgA consultar

